Nicole J. Polyakov

Statistics

Publications

Citations

259

H-Index

Active since

2019

Affiliations

Harvard University(Current)

Massachusetts General Hospital

Nicole J. Polyakov is an author at Harvard University specializing in international classification of diseases, checkpoint inhibitor therapy, and oncology.

ORCID

Publications per year

2019–2021

Publications

CRISPR screening using an expanded toolkit of autophagy reporters identifies TMEM41B as a novel autophagy factor

Christopher J. Shoemaker, T.Q. Huang, N. Weir et al. · PLoS Biology · 2019 · 153 citations · Full text

Life Sciences, Genetics, Molecular Biology +15

Patterns of Cutaneous and Noncutaneous Immune-Related Adverse Events Among Patients With Advanced Cancer

Leah L. Thompson, Nira A. Krasnow, Michael S. Chang et al. · JAMA Dermatology · 2021 · 59 citations · Full text

Medicine, Immunology, Oncology +17

Retro-2 protects cells from ricin toxicity by inhibiting ASNA1-mediated ER targeting and insertion of tail-anchored proteins

David W. Morgens, Charlene Chan, Andrew J Kane et al. · eLife · 2019 · 24 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +16

Effect of dermatological consultation on survival in patients with checkpoint inhibitor‐associated cutaneous toxicity

Leah L. Thompson, E.B. Li, Nira A. Krasnow et al. · British Journal of Dermatology · 2021 · 23 citations

Medicine, Dermatology, Oncology +17

1–4 of 4